CLEAR CELL RENAL CELL CARCINOMA
Clinical trials for CLEAR CELL RENAL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new CLEAR CELL RENAL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for CLEAR CELL RENAL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kidney cancer: experimental drug targets tumor growth
Disease control CompletedThis early-stage trial tested a new drug called ARO-HIF2 in 26 people with advanced clear cell kidney cancer that had worsened after at least two prior treatments. The goal was to find a safe dose and see if the drug could help control the disease. Participants received injection…
Matched conditions: CLEAR CELL RENAL CELL CARCINOMA
Phase: PHASE1 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New antibody drug shows promise in early cancer trial
Disease control CompletedThis early-stage study tested a new drug called CHS-388 in 145 people with advanced solid tumors (like kidney, liver, or lung cancer) that had stopped responding to standard treatments. The drug works by blocking a protein called IL-27 to help the immune system fight cancer. The …
Matched conditions: CLEAR CELL RENAL CELL CARCINOMA
Phase: PHASE1 • Sponsor: Coherus Oncology, Inc. • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
Gene-Edited immune cells take on Hard-to-Treat cancers
Disease control CompletedThis early-phase trial tested a new treatment called CTX131 for adults with several types of advanced solid tumors that had stopped responding to standard therapies. CTX131 uses a patient's own immune cells that are edited with CRISPR technology to target a protein called CD70 on…
Matched conditions: CLEAR CELL RENAL CELL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: CRISPR Therapeutics AG • Aim: Disease control
Last updated May 13, 2026 15:58 UTC
-
Drug combo helps High-Risk kidney cancer patients avoid full kidney removal
Disease control CompletedThis study tested a combination of two drugs (cadonilimab and lenvatinib) given before surgery to 39 people with kidney cancer that was hard to operate on. The goal was to shrink the tumor enough so that only the cancerous part of the kidney could be removed, sparing the rest. Th…
Matched conditions: CLEAR CELL RENAL CELL CARCINOMA
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated May 08, 2026 12:03 UTC